Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study
- PMID: 31278520
- DOI: 10.1007/s00392-019-01524-9
Incidence, predictors, and relevance of acute kidney injury in patients undergoing left atrial appendage closure with Amplatzer occluders: a multicentre observational study
Abstract
Aims: Acute kidney injury (AKI) remains a frequent complication after cardiac interventions, such as left atrial appendage closure (LAAC), yet limited data are available on the incidence and clinical implication of AKI in this setting. We sought to assess incidence, predictors and relevance of AKI after LAAC.
Methods and results: We retrospectively analyzed 95 LAAC patients in three European centers. AKI was defined according to the Acute Kidney Injury Network (AKIN) classification. The incidence of AKI was 13.7% with mild AKI in 92.3% and AKI stage > II in 7.7%. Total contrast volume was not linked to the occurrence of AKI (AKI: 127 ± 83 vs. no AKI: 109 ± 92 ml, p = 0.41), however increasing contrast volume (CV) to glomerular filtration rate (GFR) ratio (CV/GFR ratio) was associated with an increased risk of AKI (OR, per unit increase: 1.24, 95% CI 0.97-1.58, p = 0.08). ROC-analysis revealed a moderate predictive value of CV/GFR ratio for the prediction of AKI (AUC: 0.67, 95% CI 0.50-0.84, p = 0.05). Furthermore, AKI was associated with significantly increased mortality 6 months and 1 year after LAAC. No significant difference in the incidence of AKI was observed between patients with mere fluoroscopic and additional echocardiographic guidance (16.3% vs. 11.5%, p = 0.56).
Conclusion: Whereas mild AKI is common in patients after LAAC, severe AKI is rare. AKI after LAAC is associated with poor baseline renal function, increased doses of contrast (CV/GFR ratio) and impaired outcome. Future studies will be needed to elaborate the benefit of reducing or avoiding contrast volume regarding this endpoint.
Keywords: Acute kidney injury; Contrast dye volume; Left atrial appendage closure; Renal function.
Similar articles
-
Incidence, Predictors, and Prognostic Value of Acute Kidney Injury Among Patients Undergoing Left Atrial Appendage Closure.JACC Cardiovasc Interv. 2018 Jun 11;11(11):1074-1083. doi: 10.1016/j.jcin.2018.03.022. JACC Cardiovasc Interv. 2018. PMID: 29880102
-
Association of acute kidney injury with outcomes in patients undergoing percutaneous left atrial appendage closure.Catheter Cardiovasc Interv. 2021 Nov 15;98(6):E839-E846. doi: 10.1002/ccd.29711. Epub 2021 Apr 15. Catheter Cardiovasc Interv. 2021. PMID: 33856101
-
Predictors of Early (1-Week) Outcomes Following Left Atrial Appendage Closure With Amplatzer Devices.JACC Cardiovasc Interv. 2016 Jul 11;9(13):1374-83. doi: 10.1016/j.jcin.2016.04.019. JACC Cardiovasc Interv. 2016. PMID: 27388826
-
Systematic review on left atrial appendage closure with the LAmbre device in patients with non-valvular atrial fibrillation.BMC Cardiovasc Disord. 2020 Feb 12;20(1):78. doi: 10.1186/s12872-020-01349-9. BMC Cardiovasc Disord. 2020. PMID: 32050904 Free PMC article.
-
The Bermuda triangle: Chronic kidney disease, contrast-induced nephropathy, and atrial fibrillation.Cardiovasc Revasc Med. 2018 Jan;19(1 Pt A):72-74. doi: 10.1016/j.carrev.2017.08.015. Epub 2017 Sep 1. Cardiovasc Revasc Med. 2018. PMID: 29033366 Review. No abstract available.
Cited by
-
Transcatheter left atrial appendage occlusion in patients with chronic kidney disease: a systematic review and meta-analysis.Clin Res Cardiol. 2024 Oct;113(10):1485-1500. doi: 10.1007/s00392-023-02359-1. Epub 2023 Dec 19. Clin Res Cardiol. 2024. PMID: 38112741
-
Percutaneous left atrial appendage closure using the TrueFusion™ fusion-imaging technology.Clin Res Cardiol. 2020 May;109(5):646-648. doi: 10.1007/s00392-019-01566-z. Epub 2019 Nov 4. Clin Res Cardiol. 2020. PMID: 31686210
-
Risk Factors and Outcomes of AKI after LAAC Operation: A Single-Center Observational Study from Mainland China.Rev Cardiovasc Med. 2022 Sep 9;23(9):306. doi: 10.31083/j.rcm2309306. eCollection 2022 Sep. Rev Cardiovasc Med. 2022. PMID: 39077701 Free PMC article.
-
Left atrial appendage closure in patients with chronic kidney disease: results from the German multicentre LAARGE registry.Clin Res Cardiol. 2021 Jan;110(1):12-20. doi: 10.1007/s00392-020-01638-5. Epub 2020 Apr 15. Clin Res Cardiol. 2021. PMID: 32296971 Free PMC article.
-
Efficacy and safety of patients with chronic kidney disease undergoing left atrial appendage closure for atrial fibrillation.PLoS One. 2023 Oct 26;18(10):e0287928. doi: 10.1371/journal.pone.0287928. eCollection 2023. PLoS One. 2023. PMID: 37883421 Free PMC article.
References
-
- Reddy VY, Holmes D, Doshi SK et al (2011) Safety of percutaneous left atrial appendage closure: results from the watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry. Circulation 123:417–424. https://doi.org/10.1161/CIRCULATIONAHA.110.976449 - DOI - PubMed
-
- Tzikas A, Shakir S, Gafoor S et al (2016) Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention 11:1170–1179. https://doi.org/10.4244/EIJY15M01 - DOI - PubMed
-
- Holmes DR, Kar S, Price MJ et al (2014) Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol 64:1–12. https://doi.org/10.1016/j.jacc.2014.04.029 - DOI - PubMed
-
- D’Ancona G, Safak E, Ince H (2019) Left atrial appendage occlusion in patients with atrial fibrillation and high risk of fall: a clinical dilemma or a budgetary issue? Clin Res Cardiol. https://doi.org/10.1007/s00392-019-01476-0 - DOI - PubMed
-
- Seeger J, Bothner C, Dahme T et al (2016) Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk. Clin Res Cardiol 105:225–229. https://doi.org/10.1007/s00392-015-0910-8 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical